Search research articles
Contact Us
Filters
Showing results (151-160 of 395) with videos related to
Page
of 40
Sort By:
The Cancer Journal From Scientific American
|
July 1, 1995
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival
R D Gelber, B F Cole, A Goldhirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 1998
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making
B F Cole, P Solal-Céligny, R D Gelber, et al.
Journal of Pediatric Hematology/Oncology
|
February 25, 1999
Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia
B L Asselin, S Kreissman, D J Coppola, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 20, 1999
Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group
M Colleoni, K Price, M Castiglione-Gertsch, et al.
Breast (Edinburgh, Scotland)
|
December 9, 2003
Preoperative systemic treatment: prediction of responsiveness
M Colleoni, D Zahrieh, R D Gelber, et al.
Lancet (London, England)
|
February 12, 1994
Effect of systemic adjuvant treatment on first sites of breast cancer relapse
A Goldhirsch, R D Gelber, K N Price, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1994
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up
M Castiglione-Gertsch, C Johnsen, A Goldhirsch, et al.
Israel Journal of Medical Sciences
|
February 1, 1995
The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group
A Goldhirsch, R D Gelber, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2012
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
J Huober, S Gelber, A Goldhirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1987
Prognostic factors in childhood acute myelogenous leukemia
H E Grier, R D Gelber, B M Camitta, et al.
Page
of 40
Search research articles
Search
Showing results (151-160 of 395) with videos related to
Sort By:
Page
of 40
The Cancer Journal From Scientific American
|
July 1, 1995
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival
R D Gelber, B F Cole, A Goldhirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 17, 1998
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making
B F Cole, P Solal-Céligny, R D Gelber, et al.
Journal of Pediatric Hematology/Oncology
|
February 25, 1999
Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia
B L Asselin, S Kreissman, D J Coppola, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 20, 1999
Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group
M Colleoni, K Price, M Castiglione-Gertsch, et al.
Breast (Edinburgh, Scotland)
|
December 9, 2003
Preoperative systemic treatment: prediction of responsiveness
M Colleoni, D Zahrieh, R D Gelber, et al.
Lancet (London, England)
|
February 12, 1994
Effect of systemic adjuvant treatment on first sites of breast cancer relapse
A Goldhirsch, R D Gelber, K N Price, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 1994
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up
M Castiglione-Gertsch, C Johnsen, A Goldhirsch, et al.
Israel Journal of Medical Sciences
|
February 1, 1995
The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group
A Goldhirsch, R D Gelber, M Castiglione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2012
Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials
J Huober, S Gelber, A Goldhirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1987
Prognostic factors in childhood acute myelogenous leukemia
H E Grier, R D Gelber, B M Camitta, et al.
Page
of 40